Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SZSE:002437
SZSE:002437Pharmaceuticals

Global Market Insights: CNMC Goldmine Holdings And 2 Other Promising Penny Stocks

As global markets face challenges such as a record federal government shutdown and concerns over AI spending, investors are increasingly cautious about growth-oriented stocks. Amidst these broader market dynamics, the allure of penny stocks remains strong for those seeking opportunities in smaller or newer companies. While the term "penny stocks" may seem outdated, it continues to signify potential value in firms with solid financials and promising growth prospects. This article explores...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Will Solvay's (ENXTBR:SOLB) Rare Earth Deal Reveal Its Edge in Sustainable Supply Chains?

Noveon Magnetics and Solvay recently announced a multi-year supply agreement for light and heavy rare earth oxides, with Solvay providing Neodymium-Praseodymium, Dysprosium, and Terbium oxides, sourced partly from recycled materials, to support Noveon's production of permanent magnets starting in 2026. This collaboration advances a more resilient and sustainable domestic supply chain for rare earth magnets amid ongoing global supply risks and growing demand. The agreement enhances Solvay's...
NasdaqGM:MRUS
NasdaqGM:MRUSBiotechs

Did Rising Nine-Month Losses and Modest Revenue Growth Just Shift Merus' (MRUS) Investment Narrative?

Merus N.V. reported its third quarter 2025 earnings, showing revenue of US$12.15 million and a net loss of US$95.52 million, with the nine-month loss rising to US$350.21 million on revenue of US$47.47 million. While quarterly revenues edged up from last year, losses for the nine-month period grew dramatically as reported on October 31, 2025. We'll examine how Merus' ramp-up in nine-month revenues alongside widening losses shapes its current investment narrative. The end of cancer? These 29...
XTRA:KSB
XTRA:KSBMachinery

Strong Sales and Order Intake Could Be a Game Changer For KSB SE KGaA (XTRA:KSB)

KSB SE & Co. KGaA announced increased sales revenue of €2.23 billion and order intake of €2.45 billion for the first nine months of 2025, while reaffirming its earnings guidance for the year. This combination of top-line growth and maintained guidance signals continued operational momentum despite broader economic uncertainties. We'll assess how this steady growth in sales and orders shapes KSB SE & Co. KGaA's investment narrative going forward. AI is about to change healthcare. These 31...